SCHEMBL6182304

SCHEMBL6182304

CC(C)(C)CCC(O)CCC(O)CCC(C)(C)C(c1conc1O)c1conc1O

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5705323 0.76
SCHEMBL6197298 0.72 RIPK1 (0.32) RIPK1
SCHEMBL6180113 0.72
SCHEMBL13053733 0.70
SCHEMBL6184012 0.69
SCHEMBL6181121 0.68
SCHEMBL13053740 0.68
SCHEMBL6194569 0.67
SCHEMBL6184441 0.66 ACACB (0.30)
SCHEMBL8896856 0.66 RIPK1 (0.44) RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1597223-A2 HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES Esperion Therapeutics Inc. (US) 2005-11-23 EP disclosed
WO-2004067489-A2 HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2004-08-12 WO disclosed